CD27 Ligand

CD27 Ligand 詳細

英語名CD70 antigen市販薬剤の数0
治験薬の数37ターゲットの別称CD70 antigen,Surface Antigen CD70,LPFS3,CD27L,Tumor necrosis factor ligand superfamily member 7,CD27LG,CD27-L,CD70,CD70 Molecule,TNFSF7,Tumor Necrosis Factor (Ligand) Superfamily, Member 7,Tumor Necrosis Factor Ligand 8A,Ki-24 Antigen,TNLG8A,CD27 Ligand
研究&開発段階Phase 2 Clinical
英語名CD70 antigen
ターゲットの別称CD70 antigen,Surface Antigen CD70,LPFS3,CD27L,Tumor necrosis factor ligand superfamily member 7,CD27LG,CD27-L,CD70,CD70 Molecule,TNFSF7,Tumor Necrosis Factor (Ligand) Superfamily, Member 7,Tumor Necrosis Factor Ligand 8A,Ki-24 Antigen,TNLG8A,CD27 Ligand
市販薬剤の数0
治験薬の数37
研究&開発段階Phase 2 Clinical

CD27 Ligand 製品リスト

  • 属性

    Protein (14)

  • 製品ライブラリ

    オンライン (14)

  • Mouse (3)Human (11)

  • タグ

    Mouse IgG Fc Tag (2)His Tag (6)His Tag & Avi Tag (1)Fc Tag (1)His Tag & Flag Tag (2)His Tag & Avi Tag & Flag Tag (1)Llama IgG Fc Tag (1)

  • マーカー

    Unconjugated (6)Biotin-labeled (2)FITC Labeled (2)APC Labeled (1)PE Labeled (1)AF647 Labeled (1)AF488 Labeled (1)

CD27 Ligandバックグランド

Cluster of Differentiation 70 (CD70) is also known as CD27 ligand (CD27L / CD27LG), TNFSF7, TNFSF7G, is a type II transmembrane glycoprotein belonging to the TNF superfamily (TNFSF) and is a surface antigen found on activated T-and B-lymphocytes and mature dendritic cells. Binding of CD70 to its receptor CD27 induces in priming, effector functions, differentiation and memory formation of T-cells, and thus is invloved in the biological processes including T-cell activation, the proliferation of costimulated T-cells, as well as the generation of cytolytic T-cells. CD70 on T cells provides costimulatory signals that are required for T cell proliferation, clonal expansion and the promotion of effector T cell formation. CD70 on mouse B cell has been shown to inhibit terminal differentiation of activated B cells into plasma cells and enhances commitment to memory B cell responses. CD70 induces proliferation and IFNγ production, on NK cells.

CD27 Ligand分子の別称

CD70,CD27LG,TNFSF7,TNFSF7G,CD27L

抗体購入プラットフォーム

プロジェクトステージタイプ由来疾患領域適応症
CD70 VHH - 01LeadMonoclonalNanobodyHematological MalignancyNon-hodgkin lymphoma

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CusatuzumabARGX-110; JNJ-4550Phase 2 ClinicalArgenx SeLeukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms
詳細
ARX-305JNJ-0631; ARX-305; NCB-002Phase 2 ClinicalAmbrx IncLymphoma; Neoplasms
詳細
CD70.CAR NK cell therapy (Bellicum Pharma)Phase 2 ClinicalBellicum Pharmaceuticals Inc, The University Of Texas MD Anderson Cancer CenterHodgkin Disease; Lymphoma, B-Cell
詳細
ADI-270ADI-270Phase 2 ClinicalAdicet Bio IncCarcinoma, Renal Cell
詳細
CD70 Targeted CAR-T Cells Therapy(UTC Therapeutics)Phase 2 ClinicalUTC Therapeutics IncLymphoma; Solid tumours; Urologic Neoplasms
詳細
Cord Blood-derived CAR NK Cells Targeting CD19/CD70(Shanghai Tongji Hospital)Phase 2 ClinicalShanghai Tongji HospitalLymphoma, B-Cell
詳細
MP0533MP0533Phase 2 ClinicalMolecular Partners AgLeukemia, Myeloid, Acute
詳細
CTX-131CTX-131Phase 2 ClinicalCrispr Therapeutics AgCarcinoma, Renal Cell; Esophageal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, T-Cell; Mesothelioma; Neoplasms; Pancreatic Neoplasms; Uterine Cervical Neoplasms
詳細
GD2/CD70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR GD2/CD70Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteNeoplasms
詳細
CD19/70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteLeukemia, B-Cell; Lymphoma, B-Cell
詳細
PSMA/CD70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR PSMA/CD70Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteNeoplasms
詳細
SEA-CD70SEA-CD70; PF-08046040Phase 1 ClinicalSeagen IncLeukemia, Myeloid, Acute; Myelodysplastic Syndromes
詳細
anti-CD70 CAR T-cell therapy linked with modified IL-8 receptor (University of Florida)Phase 1 ClinicalUniversity Of FloridaGlioblastoma; Glioma; Ovarian Neoplasms; Pancreatic Neoplasms
詳細
CAR BCMA-CD70-T cells therapy (The Fifth Medical Center Of Pla General Hospital)Phase 1 ClinicalThe Fifth Medical Center Of Pla General Hospital (Formerly 307 Hospital)Neoplasms, Plasma Cell
詳細
Novel CAR-ITNK Cells Targeting CD70 and CLL1 therapy (Tongji Hospital)Phase 1 ClinicalTongji HospitalLeukemia, Myeloid, Acute
詳細
TGFBR-2 KO CD70 CAR NK cell therapy (The University Of Texas MD Anderson Cancer Center)Phase 1 ClinicalThe University Of Texas MD Anderson Cancer CenterAdenocarcinoma, Clear Cell
詳細
GEN1160GEN-1160; GEN1160Phase 1 ClinicalGenmab A/SCarcinoma, Renal Cell; Lymphoma, Non-Hodgkin; Nasopharyngeal Carcinoma
詳細
CD70-CAR-NK Cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of MedicineLeukemia, Myeloid, Acute; Lymphoma, T-Cell
詳細
Anti-CD70-CAR-T Cell therapy(First Song Biotechnology)Phase 1 ClinicalShanghai First Song Therapeutics Co LtdCarcinoma, Renal Cell
詳細
IB-T101Phase 1 ClinicalInceptor Bio LLCCarcinoma, Renal Cell
詳細
Anti-BCMA/CD70 CAR-T cells therapy(The Children'S Hospital, Zhejiang University School Of Medicine)Phase 1 ClinicalThe Children'S Hospital, Zhejiang University School Of MedicineLupus Erythematosus, Systemic; Nephrosis
詳細
CD70 UCAR T cells Therapy (Nanjing Calmhome Cell and Gene Engineering Institute)CHT101; CHT-101Phase 1 ClinicalNanjing Calmhome Cell and Gene Engineering Institute Co LtdCarcinoma, Renal Cell; Glioma; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms
詳細
Chimeric Antigen Recertor Treatment Targeting CD70(Baylor College of Medicine)Phase 1 ClinicalBaylor College Of MedicineBone Marrow Neoplasms; Kidney Neoplasms; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Lymphoma; Sarcoma; Solid tumours
詳細
CAR T-cell Therapy Directed to CD70(St Jude Children's Research Hospital)Phase 1 ClinicalSt. Jude Children'S Research HospitalHematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
詳細
CD70-targeted CAR-NKT Cells Therapy (CureGenetics)CGC729; CGC-729Phase 1 ClinicalSuzhou Cure Genetics Biosciences Co LtdCarcinoma, Renal Cell; Solid tumours
詳細
ALLO-329ALLO-329Phase 1 ClinicalAllogene Therapeutics IncAnti-synthetase Syndrome; Dermatomyositis; Lupus Erythematosus, Systemic; Muscular Diseases; Myositis; Scleroderma, Systemic
詳細
CD70-CART(Hrain)HR010; HR-010Phase 1 ClinicalHrain Biotechnology Co LtdCarcinoma, Renal Cell
詳細
Anti-CD19/CD70 NK cell therapy (Zhejiang University)Phase 1 ClinicalZhejiang UniversityLymphoma, B-Cell
詳細
CD70 CAR-T cell therapy (Chongqing Precision Biotech)Phase 1 ClinicalChongqing Precision Biotechnology Co LtdArthritis, Juvenile; Carcinoma, Renal Cell; Dermatomyositis; Genital Neoplasms, Female; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Scleroderma, Systemic; Sjogren's Syndrome; Solid tumours; Thymoma; Thyroid Carcinoma, Anaplastic; Uterine Cervical Neoplasms
詳細
IMM-40HIMM-40H; IMM40HPhase 1 ClinicalHematologic Neoplasms; Neoplasms; Solid tumours
詳細
ALLO-316ALLO-316Phase 1 ClinicalCellectis Sa, Overland Pharmaceuticals (Shanghai) Co LtdCarcinoma, Renal Cell; Leukemia, Myeloid, Acute
詳細
CD70 CAR T-cell therapy (Yake Biotechnology)Phase 1 ClinicalZhejiang UniversityLeukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma
詳細
C-4-29Phase 1 ClinicalChongqing Precision Biotechnology Co LtdCarcinoma, Renal Cell; Lupus Erythematosus, Systemic; Multiple Myeloma
詳細
[68Ga]Ga-NOTA-RCCB6ClinicalHuashan HospitalKidney Neoplasms; Lymphoma
詳細
[18F]RCCB6ClinicalHuashan HospitalKidney Neoplasms
詳細
CGC-738CGC-738; CGC738ClinicalSuzhou Cure Genetics Biosciences Co LtdCarcinoma, Renal Cell
詳細
CD19/CD70 CAR-NK cells therapy (Rongu Biotechnology)RG-1970ClinicalHangzhou Rongu Biotechnology Co LtdLymphoma, B-Cell; Neoplasms
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8